Addex Therapeutics Amends ATM Agreement to Boost Capital
I'm PortAI, I can summarize articles.
Addex Therapeutics has amended its At The Market Offering Agreement with H.C. Wainwright & Co., LLC to increase the maximum number of ordinary shares issuable, with an aggregate offering price of up to $3.3 million. This move aims to enhance the company's financial flexibility and strengthen its market position, potentially impacting its operations and investor confidence. Addex Therapeutics focuses on developing therapies for neurological disorders.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments